FDA Approved: LACOSAMIDE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for lacosamide submitted by Ascend Laboratories, LLC, signaling a regulatory action on this generic anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures
• Seizure Disorders

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

SUPPL AP for LACOSAMIDE (LACOSAMIDE)